Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
25.91
+0.05 (0.19%)
Dec 23, 2024, 2:44 PM EST - Market open
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.80 billion as of December 23, 2024. Its market cap has decreased by -34.72% in one year.
Market Cap
3.80B
Enterprise Value
3.32B
1-Year Change
-34.72%
Ranking
Category
Stock Price
$25.91
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $3.80B, an increase of 2,957.84%. That is a compound annual growth rate of 86.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.80B | -37.72% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 404.67% |
| Dec 31, 2019 | 895.95M | 620.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guardant Health | 3.91B |
| Option Care Health | 3.90B |
| Prestige Consumer Healthcare | 3.89B |
| ICU Medical | 3.84B |
| Avidity Biosciences | 3.80B |
| Haemonetics | 3.79B |
| Organon & Co. | 3.75B |
| Sotera Health Company | 3.75B |